E. Pickering Grant's most recent trade in Vaxcyte Inc was a trade of 16,198 Common Stock done at an average price of $2.0 . Disclosure was reported to the exchange on July 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.03 per share. | 27 Jul 2026 | 16,198 | 469,445 | - | 2.0 | 32,882 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2026 | 16,198 | 137,000 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.51 per share. | 27 Jul 2026 | 11,783 | 457,662 | - | 55.5 | 654,133 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.93 per share. | 27 Jul 2026 | 4,415 | 453,247 | - | 55.9 | 246,935 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.52 per share. | 27 Jul 2026 | 756 | 133,459 | - | 55.5 | 41,970 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.54 per share. | 27 Jul 2026 | 622 | 133,593 | - | 55.5 | 34,546 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.91 per share. | 27 Jul 2026 | 378 | 133,215 | - | 55.9 | 21,135 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.96 per share. | 27 Jul 2026 | 244 | 133,215 | - | 56.0 | 13,655 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.26 per share. | 26 Jun 2026 | 9,137 | 458,883 | - | 55.3 | 504,956 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 54.28 per share. | 26 Jun 2026 | 6,683 | 468,020 | - | 54.3 | 362,720 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 56.12 per share. | 26 Jun 2026 | 6,417 | 452,466 | - | 56.1 | 360,128 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.30 per share. | 26 Jun 2026 | 602 | 134,406 | - | 55.3 | 33,289 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.22 per share. | 26 Jun 2026 | 356 | 134,547 | - | 55.2 | 19,660 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 55.99 per share. | 26 Jun 2026 | 332 | 134,215 | - | 56.0 | 18,590 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 54.35 per share. | 26 Jun 2026 | 312 | 134,903 | - | 54.3 | 16,956 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 54.22 per share. | 26 Jun 2026 | 207 | 135,008 | - | 54.2 | 11,224 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 56.27 per share. | 26 Jun 2026 | 191 | 134,215 | - | 56.3 | 10,747 | Common Stock |
| LeonaBio Inc | Grant E. Pickering | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2026 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 52.50 per share. | 18 Jun 2026 | 22,236 | 474,703 | - | 52.5 | 1,167,390 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 52.50 per share. | 18 Jun 2026 | 1,000 | 135,215 | - | 52.5 | 52,500 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 52.50 per share. | 18 Jun 2026 | 1,000 | 135,215 | - | 52.5 | 52,500 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 52.51 per share. | 18 Jun 2026 | 225 | 496,939 | - | 52.5 | 11,815 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.79 per share. | 18 Jun 2026 | 225 | 497,164 | - | 1.8 | 403 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2026 | 225 | 0 | - | - | Stock Option (right to buy) | |
| LeonaBio Inc | Grant E. Pickering | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.32 per share. | 09 Mar 2026 | 3,685 | 496,939 | - | 59.3 | 218,594 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jan 2026 | 100,000 | 400,908 | - | 0 | Common Stock | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.41 per share. | 08 Sep 2025 | 7,356 | 500,908 | - | 32.4 | 238,408 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 02 Sep 2025 | 4,563 | 511,684 | - | 31.6 | 144,008 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 02 Sep 2025 | 3,420 | 508,264 | - | 31.6 | 107,935 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 02 Sep 2025 | 2,857 | 516,247 | - | 31.6 | 90,167 | Common Stock |
| LeonaBio Inc | Grant E. Pickering | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 04 Apr 2025 | 15,781 | 514,023 | - | 5.3 | 84,428 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2025 | 15,781 | 186,936 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2025 | 4,752 | 298,360 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.93 per share. | 04 Apr 2025 | 4,752 | 518,775 | - | 20.9 | 99,459 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 193,431 | 193,431 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 57,938 | 508,239 | - | 0 | Common Stock | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.10 per share. | 27 Feb 2025 | 7,984 | 498,242 | - | 72.1 | 575,646 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.02 per share. | 27 Feb 2025 | 2,013 | 506,226 | - | 73.0 | 146,989 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 92.03 per share. | 09 Dec 2024 | 1,029 | 136,369 | - | 92.0 | 94,701 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 92.06 per share. | 09 Dec 2024 | 961 | 136,437 | - | 92.1 | 88,470 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 93.10 per share. | 09 Dec 2024 | 222 | 136,215 | - | 93.1 | 20,668 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 93.60 per share. | 09 Dec 2024 | 154 | 136,215 | - | 93.6 | 14,414 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 92.06 per share. | 02 Dec 2024 | 11,349 | 453,952 | - | 92.1 | 1,044,789 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 94.06 per share. | 02 Dec 2024 | 2,242 | 450,301 | - | 94.1 | 210,883 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 93.06 per share. | 02 Dec 2024 | 1,409 | 452,543 | - | 93.1 | 131,123 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 18 Nov 2024 | 710 | 465,301 | - | 0 | Common Stock | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 197,784 | 197,784 | - | - | Performance Stock Option (right to buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 80,625 | 80,625 | - | - | Performance Restricted Stock Units | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2024 | 16,000 | 202,717 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 07 Nov 2024 | 16,000 | 466,011 | - | 5.4 | 85,600 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2024 | 14,129 | 153,198 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.03 per share. | 07 Nov 2024 | 14,129 | 450,011 | - | 2.0 | 28,682 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Nov 2024 | 663 | 0 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. | 07 Nov 2024 | 663 | 435,882 | - | 0.0 | 27 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 103.43 per share. | 07 Nov 2024 | 463 | 137,891 | - | 103.4 | 47,890 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 104.71 per share. | 07 Nov 2024 | 434 | 137,503 | - | 104.7 | 45,446 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 104.71 per share. | 07 Nov 2024 | 377 | 137,514 | - | 104.7 | 39,475 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 103.36 per share. | 07 Nov 2024 | 363 | 137,937 | - | 103.4 | 37,520 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 102.63 per share. | 07 Nov 2024 | 281 | 138,300 | - | 102.6 | 28,840 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 102.68 per share. | 07 Nov 2024 | 227 | 138,354 | - | 102.7 | 23,308 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 105.50 per share. | 07 Nov 2024 | 116 | 137,398 | - | 105.5 | 12,238 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 105.50 per share. | 07 Nov 2024 | 105 | 137,398 | - | 105.5 | 11,078 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 106.35 per share. | 01 Nov 2024 | 9,955 | 440,264 | - | 106.3 | 1,058,714 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 107.34 per share. | 01 Nov 2024 | 3,312 | 436,952 | - | 107.3 | 355,507 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 108.50 per share. | 01 Nov 2024 | 1,733 | 435,219 | - | 108.5 | 188,031 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 109.58 per share. | 07 Oct 2024 | 2,113 | 138,820 | - | 109.6 | 231,549 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 109.43 per share. | 07 Oct 2024 | 1,849 | 139,118 | - | 109.4 | 202,334 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 108.72 per share. | 07 Oct 2024 | 887 | 140,933 | - | 108.7 | 96,437 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 108.75 per share. | 07 Oct 2024 | 807 | 140,967 | - | 108.7 | 87,760 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 110.20 per share. | 07 Oct 2024 | 537 | 138,581 | - | 110.2 | 59,180 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 107.50 per share. | 07 Oct 2024 | 356 | 141,774 | - | 107.5 | 38,269 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 107.27 per share. | 07 Oct 2024 | 310 | 141,820 | - | 107.3 | 33,253 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 110.35 per share. | 07 Oct 2024 | 239 | 138,581 | - | 110.3 | 26,373 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 01 Oct 2024 | 20,000 | 470,219 | - | 5.4 | 107,000 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 20,000 | 238,717 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 20,000 | 218,717 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.35 per share. | 01 Oct 2024 | 20,000 | 470,219 | - | 5.4 | 107,000 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 114.28 per share. | 01 Oct 2024 | 9,627 | 455,693 | - | 114.3 | 1,100,183 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 114.20 per share. | 01 Oct 2024 | 9,429 | 456,485 | - | 114.2 | 1,076,820 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 114.27 per share. | 01 Oct 2024 | 7,088 | 454,507 | - | 114.3 | 809,967 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 114.93 per share. | 01 Oct 2024 | 6,266 | 450,219 | - | 114.9 | 720,176 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 114.98 per share. | 01 Oct 2024 | 5,474 | 450,219 | - | 115.0 | 629,411 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 113.37 per share. | 01 Oct 2024 | 4,899 | 465,320 | - | 113.4 | 555,400 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 113.35 per share. | 01 Oct 2024 | 4,305 | 465,914 | - | 113.3 | 487,955 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 114.99 per share. | 01 Oct 2024 | 4,288 | 450,219 | - | 115.0 | 493,056 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 113.38 per share. | 01 Oct 2024 | 3,624 | 461,595 | - | 113.4 | 410,893 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.15 per share. | 03 Sep 2024 | 13,669 | 465,219 | - | 110.1 | 1,505,640 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.03 per share. | 23 Aug 2024 | 15,000 | 493,888 | - | 2.0 | 30,450 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2024 | 15,000 | 167,327 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 79.25 per share. | 23 Aug 2024 | 8,314 | 478,888 | - | 79.3 | 658,906 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 78.65 per share. | 23 Aug 2024 | 6,686 | 487,202 | - | 78.7 | 525,861 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 78.80 per share. | 01 Aug 2024 | 1,308 | 142,130 | - | 78.8 | 103,074 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 78.78 per share. | 01 Aug 2024 | 1,308 | 142,130 | - | 78.8 | 103,049 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.03 per share. | 23 Jul 2024 | 15,000 | 493,888 | - | 2.0 | 30,450 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2024 | 15,000 | 182,327 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 84.53 per share. | 23 Jul 2024 | 9,282 | 478,888 | - | 84.5 | 784,589 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 83.83 per share. | 23 Jul 2024 | 5,718 | 488,170 | - | 83.8 | 479,323 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 75.92 per share. | 01 Jul 2024 | 751 | 143,995 | - | 75.9 | 57,016 | Common Stock |
| Vaxcyte Inc | Grant E. Pickering | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 75.84 per share. | 01 Jul 2024 | 674 | 144,072 | - | 75.8 | 51,119 | Common Stock |